QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TECH

QT74Bio-Techne Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
57.94
+2.94+5.35%
OverviewShort InterestFilings
TECHQT74Bio-Techne Corporation·NASDAQ
OverviewShort InterestFilings
57.94+5.35%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E78.25EPS (ttm)
0.69
Insider Own1.63%
Shs Outstand156.57M
Perf Week7.26%
Market Cap8.61BForward P/E27.45EPS next Y2.11Insider Trans0.28%Shs Float-Perf Month27.42%
Enterprise Value8.69BPEG-EPS next Q0.55Inst Own-Short Float-Perf Quarter12.31%
Income110.22MP/S7.11EPS this Y180.58%Inst Trans-Short Ratio-Perf Half Y0.87%
Sales1.21BP/B4.11EPS next Y9.01%ROA4.30%Short Interest-Perf YTD-1.48%
Book/sh13.32P/C29.08EPS next 5Y8.27%ROE5.49%52W High72.16 -19.71%Perf Year17.05%
Cash/sh1.34P/FCF31.94EPS past 3/5Y-ROIC4.75%52W Low43.20 34.12%Perf 3Y-
Dividend Est.0.32 (0.55%)EV/EBITDA33.69Sales past 3/5Y3.32% 10.55%Gross Margin64.96%Volatility2.62% 2.55%Perf 5Y-
Dividend TTM0.32 (0.55%)EV/Sales7.18EPS Y/Y TTM87.62%Oper. Margin12.70%ATR (14)2.31Perf 10Y-
Dividend Ex-DateMay 18, 2026Quick Ratio3.18Sales Y/Y TTM4.49%Profit Margin9.05%RSI (14)64.79Recom2.25
Dividend Gr. 3/5Y0.00% 0.00%Current Ratio4.49EPS Q/Q9.52%SMA2011.05%Beta1.05Target Price59.17
Payout45.47%Debt/Eq0.14Sales Q/Q-1.58%SMA5010.39%Rel Volume1.32Prev Close55.00
Employees3,100LT Debt/Eq0.22EarningsAug 05SMA2000.79%Avg Volume2.85MPrice57.94
IPO DateFeb 09, 1989Option/ShortYes / YesEPS/Sales Surpr.6.98% 2.07%Net Debt/EBITDA0.31Volume3,773,089Change5.35%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26InitiatedPiper SandlerNeutral$65
May-14-26ResumedRBC CapitalOutperform$73 → $62
May-07-26ReiteratedEvercore ISI$54 → $50
May-07-26ReiteratedStifel NicolausBuy$65 → $50
May-07-26ReiteratedRobert W. Baird$70 → $49
Feb-05-26ReiteratedStifel NicolausBuy$60 → $65
Feb-05-26ReiteratedRobert W. Baird$61 → $70
Feb-05-26ReiteratedUBSBuy$79
Jan-05-26ReiteratedEvercore ISI$68 → $62
Jan-05-26DowngradeEvercore ISI GroupOutperform → In Line
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
6/30/2025
FY 2024
6/30/2024
FY 2023
6/30/2023
FY 2022
6/30/2022
FY 2021
6/30/2021
FY 2020
6/30/2020
FY 2019
6/30/2019
FY 2018
6/30/2018
Total Revenue1,2111,2201,159
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A424429389
Gross Profit786790770
Selling, General and Administrative Excl. Other362415393
Research and Development969997
Other Operating Expense17517473
Operating Income153102207
Interest Expense10916
Unusual Expense
———
Non-Operating Income (Expense)-3-55
Net Income Before Taxes14798186
Income Taxes382518
Consolidated Net Income10973168
Net Income From Continuing Operations10973168
Net Income10973168
EPS (Recurring)0.710.471.07
EPS (Basic, Before Extraordinaries)0.710.471.07
EPS (Diluted)0.690.461.05
EBITDA258217313
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio83.97111.85—
Price To Sales Ratio7.466.66—
Gross Margin64.9164.7566.44
Operating Margin12.638.3617.86
Net Margin9.005.9814.50
Shares Outstanding156158158
Market Capitalization9,0398,129—
Operating Lease Expense
———
Insider Trading Volume
$61.77$55.40$49.03$42.66$36.29● Close Price0.00M0.48M0.96M1.44M1.92MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Crouse Steven C.President - Diag & Spatial BiJun 02 '26Option Exercise0.001,20006,977Jun 04 12:00 AM
Herr Amy E.DirectorMay 08 '26Option Exercise47.6013,272631,7486,836May 12 12:00 AM
Herr Amy E.DirectorMay 08 '26Sale48.286,636320,386200May 12 12:00 AM
Hippel JamesCFOMay 05 '26Option Exercise47.60124,0005,902,400210,625May 07 12:00 AM
Bohnen ShaneSVP - General CounselMay 05 '26Option Exercise47.6016,800799,68014,304May 07 12:00 AM
Kelderman KimChief Executive OfficerMay 05 '26Option Exercise47.6053,3842,541,07889,750May 07 12:00 AM
Crouse Steven C.President - Diag & Spatial BiMay 01 '26Option Exercise0.001,58806,688May 05 12:00 AM
Kelderman KimChief Executive OfficerApr 22 '26Option Exercise23.8022,688539,97464,421Apr 24 12:00 AM
Hippel JamesCFOApr 22 '26Option Exercise23.80124,0002,951,200204,722Apr 24 12:00 AM
Kelderman KimChief Executive OfficerApr 14 '26Option Exercise23.8073,0001,737,40085,165Apr 16 12:00 AM
Bohnen ShaneSVP - General CounselApr 03 '26Option Exercise0.004,51806,644Apr 07 12:00 AM
Herr Amy E.DirectorFeb 17 '26Sale59.101,976116,791200Feb 19 12:00 AM
Herr Amy E.DirectorFeb 03 '26Option Exercise0.007602,192Feb 05 12:00 AM
McManus MatthewPresident - Diag & Spatial BioFeb 01 '26Option Exercise0.009,24209,356Feb 03 12:00 AM
Hippel JamesCFONov 03 '25Option Exercise0.0049,4080154,587Nov 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR